percent of americans on glp 1 Big shift in U.S. health! A new Gallup poll shows 11% now taking GLP-1 drugs, coinciding with obesity rates dropping to 36.4% (down from 39.9% in 2022). Promising progress in what percent of americans are

And she said the states prior authorization requirements for the drug could discourage primary care doctors

They show up in clinical trial design, in tolerability profiles, in the types of metabolic benefits each compound delivers, and in the practical timelines for when researchers might actually be able to access them

Weight monitoring forms a cornerstone of GLP-1 therapy assessment, but the approach requires consistency and proper interpretation

Oestreicher, J

Important considerations : These strategies support overall metabolic health but should not be viewed as substitutes for medical treatment when indicated